Literature DB >> 15009176

Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter.

L Baseggio1, L Bartholin, A Chantome, C Charlot, R Rimokh, G Salles.   

Abstract

Single nucleotide polymorphisms in the tumour necrosis factor alpha (TNF-alpha) promoter region may modulate TNF-alpha gene transcriptional activity by modifying the binding of transcription factors. Here we confirm that a specific DNA complex binds preferentially the variant TNF2 allele in various cell types and demonstrate that activating protein (AP)-2, myeloid zinc finger gene 1 (MZF-1) and Sp1 are not involved in this complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009176     DOI: 10.1111/j.1365-2370.2004.00440.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  10 in total

1.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

2.  Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.

Authors:  Francis E Lotrich; Barry Sears; Robert K McNamara
Journal:  J Psychosom Res       Date:  2013-07-26       Impact factor: 3.006

3.  Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.

Authors:  Francis E Lotrich; Robert E Ferrell; Mordechai Rabinovitz; Bruce G Pollock
Journal:  Clin Neuropharmacol       Date:  2010-07       Impact factor: 1.592

Review 4.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 5.  Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation.

Authors:  Diana M Girnita; Gilbert Burckart; Adriana Zeevi
Journal:  Curr Opin Immunol       Date:  2008-08-28       Impact factor: 7.486

6.  SNP-SNP interactions in breast cancer susceptibility.

Authors:  Venüs Ummiye Onay; Laurent Briollais; Julia A Knight; Ellen Shi; Yuanyuan Wang; Sean Wells; Hong Li; Isaac Rajendram; Irene L Andrulis; Hilmi Ozcelik
Journal:  BMC Cancer       Date:  2006-05-03       Impact factor: 4.430

7.  Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter.

Authors:  João Eurico Fonseca; João Cavaleiro; José Teles; Elsa Sousa; Valeska L Andreozzi; Marília Antunes; Maria A Amaral-Turkman; Helena Canhão; Ana F Mourão; Joana Lopes; Joana Caetano-Lopes; Pamela Weinmann; Marta Sobral; Patrícia Nero; Maria J Saavedra; Armando Malcata; Margarida Cruz; Rui Melo; Araceli Braña; Luis Miranda; José V Patto; Anabela Barcelos; José Canas da Silva; Luís M Santos; Guilherme Figueiredo; Mário Rodrigues; Herberto Jesus; Alberto Quintal; Teresa Carvalho; José A Pereira da Silva; Jaime Branco; Mário Viana Queiroz
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  Tumor necrosis factor-alpha gene promoter region polymorphism and the risk of coronary heart disease.

Authors:  Gul Zareen Asifa; Afrose Liaquat; Iram Murtaza; Syed Ali Raza Kazmi; Qamar Javed
Journal:  ScientificWorldJournal       Date:  2013-12-05

9.  Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma.

Authors:  Haisheng Guo; Yunhui Xing; Ailan Mu; Xia Li; Tingshan Li; Xia Bian; Chunmei Yang; Xiaolei Zhang; Yuefen Liu; Xunguo Wang
Journal:  Onco Targets Ther       Date:  2016-08-25       Impact factor: 4.147

10.  Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario.

Authors:  Laurent Briollais; Yuanyuan Wang; Isaac Rajendram; Venus Onay; Ellen Shi; Julia Knight; Hilmi Ozcelik
Journal:  BMC Med       Date:  2007-08-07       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.